Acelyrin, Inc. (SLRN)
USD 3.27
(-6.57%)
USD 3.27
(-6.57%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -169.7 Million | -61.52 Million | -4.97 Million |
| Net Income | -381.64 Million | -64.77 Million | -41.83 Million |
| Depreciation & Amortization | 115 Thousand | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 47.31 Million | 4.05 Million | 233 Thousand |
| Change in working capital | 52.07 Million | -67 Thousand | 11.62 Million |
| Other non-cash items | 133.21 Million | -733 Thousand | 25 Million |
| Investing Cash Flow | -447.74 Million | -47.87 Million | -25 Million |
| Investments in PPE | -12.29 Million | - | -25 Million |
| Acquisitions | 10 Million | -83 Thousand | -25 Million |
| Investment purchases | -956.51 Million | -175.97 Million | - |
| Sales/Maturities of investments | 511.05 Million | 128.17 Million | - |
| Other Investing Activities | -455.45 Million | -47.79 Million | -25 Million |
| Financing Cash Flow | 568.43 Million | 274.26 Million | 124.72 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -8.32 Million | - | - |
| Common Stock Issuance | 574.13 Million | 263.48 Million | 124.72 Million |
| Other Financing Activities | -8.32 Million | 274.26 Million | 124.72 Million |
| Accounts receivables | - | - | - |
| Accounts payables | 34.44 Million | 3.77 Million | 1.11 Million |
| Inventory | - | - | - |
| Other working capital | 1.69 Million | -3.84 Million | 10.5 Million |
| Cash at beginning of period | 267.11 Million | 102.24 Million | 7.5 Million |
| Cash at end of period | 218.09 Million | 267.11 Million | 102.24 Million |
| Capital Expenditure | -12.29 Million | - | -25 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -49.01 Million | 164.86 Million | 94.74 Million |
| Free Cash Flow | -181.99 Million | -61.52 Million | -29.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -85.67 Million | -34.97 Million | -95.21 Million | -381.64 Million | -83.94 Million | -26.03 Million |
| Depreciation & Amortization | 116 Thousand | 55 Thousand | 48 Thousand | 115 Thousand | 40 Thousand | 27.00 |
| Deferred income taxes | - | - | 4.65 Million | - | -4.65 Million | - |
| Stock-based compensation | 10.17 Million | 20.16 Million | 16.36 Million | 47.31 Million | 15.31 Million | 8.5 Million |
| Change in working capital | 32.74 Million | -30.22 Million | 10.05 Million | 52.07 Million | 34.02 Million | -3.23 Million |
| Other non-cash items | -23.95 Million | 46 Thousand | 45 Thousand | 133.21 Million | 93 Thousand | -10.85 Million |
| Investing Cash Flow | -89.18 Million | 100.89 Million | -92.6 Million | -447.74 Million | -134.8 Million | -267.87 Million |
| Investments in PPE | -814 Thousand | -55 Thousand | -98 Thousand | -12.29 Million | -197 Thousand | -1.76 Million |
| Acquisitions | - | 7 Million | -10 Million | 10 Million | 10 Million | - |
| Investment purchases | -293.95 Million | -198 Million | -418.52 Million | -956.51 Million | -271.87 Million | -266.11 Million |
| Sales/Maturities of investments | 205.58 Million | 291.95 Million | 326.01 Million | 511.05 Million | 137.26 Million | - |
| Other Investing Activities | -88.36 Thousand | 7 Million | -92.5 Thousand | -455.45 Million | -134.61 Thousand | -266.11 Million |
| Financing Cash Flow | -289 Thousand | 2.8 Million | 2.59 Million | 568.43 Million | -499 Thousand | 566.46 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -289.00 | - | 8824.00 | -8.32 Million | -499.00 | -8325.00 |
| Common Stock Issuance | -289 Thousand | 2.8 Million | 2.59 Million | 574.13 Million | -530 Thousand | 574.79 Million |
| Other Financing Activities | -289 Thousand | 2807.00 | 2596.00 | -8.32 Million | 31 Thousand | 566.46 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 30.72 Million | -31.92 Million | 23.21 Million | 34.44 Million | 10.1 Million | -1.87 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.01 Million | 1698.00 | -13.16 Thousand | 1.69 Million | 23.91 Million | -1.36 Million |
| Cash at beginning of period | 264.5 Million | 218.09 Million | 381.73 Million | 267.11 Million | 556.16 Million | 289.19 Million |
| Cash at end of period | 128.21 Million | 264.5 Million | 218.09 Million | 218.09 Million | 381.73 Million | 556.16 Million |
| Capital Expenditure | -814 Thousand | -55 Thousand | -98 Thousand | -12.29 Million | -197 Thousand | -1.76 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -136.28 Million | 46.4 Million | -163.64 Million | -49.01 Million | -174.43 Million | 266.97 Million |
| Free Cash Flow | -47.08 Million | -57.35 Million | -73.72 Million | -181.99 Million | -39.32 Million | -33.38 Million |
000227
ASGR
JAIPURKURT
051910
DUVNF
ASYL